Monographie - Hydrocortisone - Stabilis 4.0

Dernière mise à jour :
18/04/2024

Antiinflammatoire

Hydrocortisone

Solution buvable

Sachet papier

Stabilité des préparations

Stabilité en mélange

Facteur influençant la stabilité

Compatibilités

Bibliographie

Pdf

Structure chimique

Solution buvable

Bibliographie

Solution buvable

Bibliographie : Hydrocortisone

	Type	Source
909	Revue	Chong G, Decarie D, Ensom M.H.H. Stability of hydrocortisone in extemporaneously compounded suspensions. J Informed Pharmacother 2003 ; 13: 100-110.
2538	Revue	Fawcett JP, Boulton DW, Jiang R, Woods DJ. Stability of hydrocortisone oral suspensions prepared from tablets and powder. Ann Pharmacotherapy 1995 ;29:987-990.
2835	Revue	Das Gupta V. Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Int J Pharm Compound 2007 ; 11, 3: 259-261.
3755	Revue	Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R. Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition. Int J Pharm Compound 2014 ; 18, 5: 427-431.
3810	Revue	Geiger C M, Sorenson B, Whaley P. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF. Int J Pharm Compound 2015 ; 19, 5 : 420-427.
3811	Revue	Nahata Milap C. Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures. Int J Pharm Compound 2015 ; 19, 5 : 428-431.
4063	Revue	Manchanda A, Laracy M, Savji T, Bogner R. Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension. Int J Pharm Compound 2018 ;22,1:66-75
4198	Revue	Uriel M, Gomez-Rincon C, Marro D. Stability of regularly prescribed oral liquids formulated with SyrSpend® SF. Pharmazie 2018 73;196-201
4530	Revue	Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Int J Pharm Compound 2021 ;25,5:431-439

Mentions Légales